Cargando…

Expression and Functional Evaluation of Recombinant Anti-receptor Activator of Nuclear Factor Kappa-B Ligand Monoclonal Antibody Produced in Nicotiana benthamiana

Denosumab, an anti-receptor activator of nuclear factor-kappa B ligand antibody (anti-RANKL), is a fully human monoclonal antibody (mAb) available for the treatment of osteoporosis. In the present study, an anti-RANKL mAb was transiently expressed using the geminiviral expression system in Nicotiana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boonyayothin, Wanuttha, Sinnung, Sirorut, Shanmugaraj, Balamurugan, Abe, Yoshito, Strasser, Richard, Pavasant, Prasit, Phoolcharoen, Waranyoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Plant Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261044/ https://www.ncbi.nlm.nih.gov/pubmed/34249053 http://dx.doi.org/10.3389/fpls.2021.683417

Ejemplares similares

Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana
por: Rattanapisit, Kaewta, et al.
Publicado: (2020)

Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2020)

Recombinant Human Dentin Matrix Protein 1 (hDMP1) Expressed in Nicotiana benthamiana Potentially Induces Osteogenic Differentiation
por: Ahmad, Aktsar Roskiana, et al.
Publicado: (2019)

Development of a plant-produced recombinant monoclonal antibody against Δ-9-tetrahydrocannabinol (Δ9-THC) for immunoassay application
por: Boonyayothin, Wanuttha, et al.
Publicado: (2022)

Functional Characterization of Pembrolizumab Produced in Nicotiana benthamiana Using a Rapid Transient Expression System
por: Phakham, Tanapati, et al.
Publicado: (2021)

Recombinant human osteopontin expressed in Nicotiana benthamiana stimulates osteogenesis related genes in human periodontal ligament cells
por: Rattanapisit, Kaewta, et al.
Publicado: (2017)

Expression optimization, purification and in vitro characterization of human epidermal growth factor produced in Nicotiana benthamiana
por: Hanittinan, Oranicha, et al.
Publicado: (2020)

Rapid transient expression of functional human vascular endothelial growth factor in Nicotiana benthamiana and characterization of its biological activity
por: Bulaon, Christine Joy I., et al.
Publicado: (2020)

Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2020)

Plant-produced recombinant Osteopontin-Fc fusion protein enhanced osteogenesis
por: Rattanapisit, Kaewta, et al.
Publicado: (2019)

Development of SARS-CoV-2 neutralizing antibody detection assay by using recombinant plant-produced proteins
por: Jirarojwattana, Perawat, et al.
Publicado: (2023)

Author Correction: Effect of plant produced Anti-hIL-6 receptor antibody blockade on pSTAT3 expression in human peripheral blood mononuclear cells
por: Kaewbandit, Namthip, et al.
Publicado: (2023)

Effect of plant produced Anti-hIL-6 receptor antibody blockade on pSTAT3 expression in human peripheral blood mononuclear cells
por: Kaewbandit, Namthip, et al.
Publicado: (2023)

Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2020)

Recombinant human dentin matrix protein 1 (DMP1) induces the osteogenic differentiation of human periodontal ligament cells
por: Ahmad, Aktsar Roskiana, et al.
Publicado: (2019)

Potential for Developing Plant-Derived Candidate Vaccines and Biologics against Emerging Coronavirus Infections
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2021)

SARS‐CoV‐2 omicron variant: Could it be another threat?
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Plant-produced SARS-CoV-2 receptor binding domain (RBD) variants showed differential binding efficiency with anti-spike specific monoclonal antibodies
por: Rattanapisit, Kaewta, et al.
Publicado: (2021)

Immunogenicity and efficacy of recombinant subunit SARS-CoV-2 vaccine candidate in the Syrian hamster model
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Harnessing the Potential of Plant Expression System towards the Production of Vaccines for the Prevention of Human Papillomavirus and Cervical Cancer
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Reproducibility and flexibility of monoclonal antibody production with Nicotiana benthamiana
por: Swope, Kelsi, et al.
Publicado: (2022)

Vacuolar targeting of recombinant antibodies in Nicotiana benthamiana
por: Ocampo, Carolina Gabriela, et al.
Publicado: (2016)

Biotechnological Insights on the Expression and Production of Antimicrobial Peptides in Plants
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2021)

Plant-produced recombinant SARS-CoV-2 receptor-binding domain; an economical, scalable biomaterial source for COVID-19 diagnosis
por: Rattanapisit, Kaewta, et al.
Publicado: (2021)

Engineering of human-type O-glycosylation in Nicotiana benthamiana plants
por: Strasser, Richard
Publicado: (2013)

Transient Expression of Tetrameric Recombinant Human Butyrylcholinesterase in Nicotiana benthamiana
por: Alkanaimsh, Salem, et al.
Publicado: (2016)

Transient Expression of Glycosylated SARS-CoV-2 Antigens in Nicotiana benthamiana
por: Ruocco, Valentina, et al.
Publicado: (2022)

Cost‐effective production of tag‐less recombinant protein in Nicotiana benthamiana
por: Islam, Md Reyazul, et al.
Publicado: (2018)

Site-Specific Glycosylation of Recombinant Viral Glycoproteins Produced in Nicotiana benthamiana
por: Margolin, Emmanuel, et al.
Publicado: (2021)

Production of Recombinant Active Human TGFβ1 in Nicotiana benthamiana
por: Soni, Aditya Prakash, et al.
Publicado: (2022)

An oligosaccharyltransferase from Leishmania major increases the N‐glycan occupancy on recombinant glycoproteins produced in Nicotiana benthamiana
por: Castilho, Alexandra, et al.
Publicado: (2018)

Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2
por: Siriwattananon, Konlavat, et al.
Publicado: (2021)

Oligomerization status influences subcellular deposition and glycosylation of recombinant butyrylcholinesterase in Nicotiana benthamiana
por: Schneider, Jeannine D, et al.
Publicado: (2014)

Transient Recombinant Protein Production in Glycoengineered Nicotiana benthamiana Cell Suspension Culture
por: Sukenik, Sara C., et al.
Publicado: (2018)

Genome and transcriptome characterization of the glycoengineered Nicotiana benthamiana line ΔXT/FT
por: Schiavinato, Matteo, et al.
Publicado: (2019)

A recombinant subunit vaccine candidate produced in plants elicits neutralizing antibodies against SARS-CoV-2 variants in macaques
por: Khorattanakulchai, Narach, et al.
Publicado: (2022)

Protection of Recombinant Mammalian Antibodies from Development-Dependent Proteolysis in Leaves of Nicotiana benthamiana
por: Robert, Stéphanie, et al.
Publicado: (2013)

Three unrelated protease inhibitors enhance accumulation of pharmaceutical recombinant proteins in Nicotiana benthamiana
por: Grosse‐Holz, Friederike, et al.
Publicado: (2018)

Production of Bioactive Recombinant Reteplase by Virus-Based Transient Expression System in Nicotiana benthamiana
por: Ma, Ting, et al.
Publicado: (2019)

Effect of the At-CDC27a gene on Nicotiana benthamiana phenotype and accumulation of recombinant proteins
por: Kopertekh, Lilya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u5j2g925j47h13bvhsjr0q1nbi